Desjardins Clarissa 4
4 · Xenon Pharmaceuticals Inc. · Filed Jun 2, 2020
Insider Transaction Report
Form 4
Desjardins Clarissa
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-01+10,000→ 10,000 totalExercise: $13.11Exp: 2030-05-31→ Common Shares (10,000 underlying)
Footnotes (1)
- [F1]One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.